Skip to content

Group Enhanced Cognitive Behaviour Therapy (CBT-E) for Eating Disorders

A randomised controlled trial of group Enhanced Cognitive Behaviour Therapy (CBT-E) versus a waitlist control condition for adult women with eating disorders: Outcomes for eating disorder symptoms and perfectionism, low self-esteem, mood intolerance and interpersonal difficulties

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000183785
Enrollment
80
Registered
2013-02-15
Start date
2013-06-01
Completion date
2017-02-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to evaluate the efficacy of group Enhanced Cognitive Behaviour Therapy (CBT-E) for eating disorders in adults. It is hypothesised that, on average, group CBT-E will result in significant pre- to post-treatment improvements in eating disorder symptoms and in symptoms relating to perfectionism, low self-esteem, mood intolerance and interpersonal problems. It is also hypothesised that group CBT-E will be significantly more effective than a waitlist control condition in producing changes in symptoms.

Interventions

Enhanced cognitive behavioural therapy (CBT-E) is a psychological treatment that is suitable for use with all forms of eating disorders. The treatment focuses on addressing the behaviours, emotions, thoughts and beliefs associated with eating disorders. The treatment also addresses additional mechanisms that, for some, act as a barrier for change and maintain eating disorder symptoms. In this trial, the intervention will consist of group CBT-E delivered on an outpatient basis. Groups will run o

Enhanced cognitive behavioural therapy (CBT-E) is a psychological treatment that is suitable for use with all forms of eating disorders. The treatment focuses on addressing the behaviours, emotions, thoughts and beliefs associated with eating disorders. The treatment also addresses additional mechanisms that, for some, act as a barrier for change and maintain eating disorder symptoms. In this trial, the intervention will consist of group CBT-E delivered on an outpatient basis. Groups will run once per week for 2 hours, over a 20 week period. Approximately 10 adult women will take part in each group, and groups will be led by 2 facilitators. Individual research assessments will be scheduled pre-treatment, mid-treatment, post-treatment and at 3-months post-treatment follow-up. The research assessments will involve completing a series of self-report questionnaires regarding depressive, anxiety and stress symptoms (the Depression Anxiety Stress Scale); perfectionism (the Clinical Perfectionism Questionnaire); self-esteem (the Rosenberg Self-Esteem Scale); self-efficacy (General Perceived Self-Efficacy Scale); relationship difficulties (Inventory of Interpersonal Problems); problems with tolerating emotions (Distress Tolerance Scale and Tolerance of Mood States Scale); problems with tolerating uncertainty (Intolerance of Uncertainty Scale); repetitive thinking (Repetitive Thinking Questionnaire); quality of life (Quality of Life and Satisfaction Questionnaire); the tendency to think in 'all of nothing' terms (Dichotomous Thinking Scale); goal setting (Conditional Goal Setting); personality traits (Screening Test for Comorbid Personality Disorders); body image (Body Image Concern Inventory); and eating disorder symptoms (Eating Disorder Examination-Questionnaire). These self-report questionnaires may be completed in participant's own time if preferred, and should take approximately 30 minutes at each assessment point. At pre-treatment only, the research assessment will also include an individual clinical interview with a psychologist. This interview will cover general background information, current eating disorder symptoms (assessed using the Eating Disorder Examination, a semi-structured interview), and other psychological difficulties (assessed using the MINI Neuropsychiatric Interview, a semi-structured interview). Height and weight will be measured. This assessment will last approximately 90 minutes.

Sponsors

Dr Karina Allen
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria are being female; aged 18 years or older; meeting DSM-5 criteria for an eating disorder; having a Body Mass Index >18.5 and <30 (healthy weight or overweight); and having no other medical or psychiatric difficulties requiring urgent attention. Addtionally, all participants will provide informed consent and will be required to have their physical health monitored by a General Practitioner for the duration of group treatment and must not be involved in any other concurrent eating disorder treatments.

Exclusion criteria

Exclusion criteria are being medically compromised (as determined by medical doctor); having a Body Mass Index (BMI) that indicates underweight (BMI <18.5) or obesity (BMI >30); being at risk of suicide (assessed during pre-treatment clinical assessment); the presence of severe psychological comorbidity that requires more immediate treatment; or inability to attend the full duration of treatment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026